Cerity Partners’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $537K | Buy |
9,722
+477
| +5% | +$26.4K | ﹤0.01% | 1816 |
|
|
2025
Q1 | $447K | Sell |
9,245
-3,811
| -29% | -$184K | ﹤0.01% | 1823 |
|
|
2024
Q4 | $518K | Sell |
13,056
-1,185
| -8% | -$47K | ﹤0.01% | 1736 |
|
|
2024
Q3 | $641K | Buy |
14,241
+3,005
| +27% | +$135K | ﹤0.01% | 1636 |
|
|
2024
Q2 | $389K | Sell |
11,236
-690
| -6% | -$23.9K | ﹤0.01% | 1670 |
|
|
2024
Q1 | $345K | Buy |
11,926
+661
| +6% | +$19.1K | ﹤0.01% | 1788 |
|
|
2023
Q4 | $258K | Hold |
11,265
| – | – | ﹤0.01% | 1595 |
|
|
2023
Q3 | $188K | Sell |
11,265
-725
| -6% | -$12.1K | ﹤0.01% | 1284 |
|
|
2023
Q2 | $331K | Hold |
11,990
| – | – | ﹤0.01% | 1353 |
|
|
2023
Q1 | $276K | Buy |
+11,990
| New | +$276K | ﹤0.01% | 1561 |
|
|
2022
Q3 | – | Sell |
-11,640
| Closed | -$92K | – | 1242 |
|
|
2022
Q2 | $92K | Buy |
+11,640
| New | +$92K | ﹤0.01% | 1133 |
|